NORMAL SITUATION

ALTRA VIA

Export PDF

Company — Normal situation.

Financial year 2024 · Closed on 31/12/2024

Net result70,3 k €-67,6 %over 1 year
Gross margin300,7 k €-3,4 %over 1 year
Equity527,9 k €+15,4 %over 1 year
Workforce0,6 ETP

Identity

Source · BCE/KBO

ALTRA VIA is a company registered in Belgium. It employs on average 0,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0760.519.788
Legal form
Private limited company
Contributed capital
10 000,00 €
Latest accounts
31/12/2024
Average workforce
0,6 ETP
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 4 filings

Trend over 4 financial years

2024202320222021
Income statement
Gross margin300,7 k €311,2 k €152,8 k €156,3 k €
EBITDA247,7 k €309,7 k €152,4 k €156,2 k €
Operating result101,9 k €294 k €141,7 k €150,5 k €
Net result70,3 k €216,9 k €111,8 k €118,9 k €
Balance sheet
Equity527,9 k €457,5 k €240,7 k €128,9 k €
Total assets781,4 k €875,8 k €776,2 k €429,6 k €
Cash120,3 k €85 k €24,2 k €24,7 k €
Debts249 k €413,8 k €535,5 k €300,7 k €
Other
Workforce0,6 ETP–––

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 2 ended

Active mandates

MiCa EYECARE

Director · 0827.774.541

Represented by Michel Daelman

Active

Ended mandates

MiCa EYECARE

Director · 0827.774.541

Represented by Michel Daelman

Ended
MiCa EYECARE

Director · 0827.774.541

Represented by Michel Daelman

Ended

Full financial information

Source · NBB
2024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202224/12/2020
Closing of the financial year31/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months13 months
Filing date18/08/202531/12/202427/08/202330/08/2022
General meeting15/05/202521/06/202416/06/202317/06/2022
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202415/05/202518/08/2025DutchPDF
Abridged model31/12/202321/06/202431/12/2024DutchPDF
Abridged model31/12/202216/06/202327/08/2023DutchPDF
Abridged model31/12/202117/06/202230/08/2022DutchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 2 ended

Active mandates

MiCa EYECARE

Director · 0827.774.541

Represented by Michel Daelman

Active

Ended mandates

MiCa EYECARE

Director · 0827.774.541

Represented by Michel Daelman

Ended
MiCa EYECARE

Director · 0827.774.541

Represented by Michel Daelman

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution28/01/2026
    RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Other18/11/2025
    DIVERSEN
    PDF
  • Mandates17/06/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other29/12/2020
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202470,3 k €↓
  2. 2023
    Annual accounts 2023216,9 k €↑
  3. 2022
    Annual accounts 2022111,8 k €↓
  4. 2021
    Annual accounts 2021118,9 k €